MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.06.25 Share Price

Warrant

DE000ME6VDA6

Market Closed - Börse Stuttgart 16:58:25 07/06/2024 BST
0.036 EUR +2.86% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.06.25
Current month+5.88%
1 month-7.69%
Date Price Change
07/06/24 0.036 +2.86%
06/06/24 0.035 +2.94%
05/06/24 0.034 0.00%
04/06/24 0.034 0.00%
03/06/24 0.034 0.00%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 04:58 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN ME6VDA
ISINDE000ME6VDA6
Date issued 12/01/2024
Strike 140 $
Maturity 20/06/2025 (376 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.092
Lowest since issue 0.024
Delta0.05x
Omega 9.620
Premium67.26x
Gearing201.85x
Moneyness 0.5996
Difference Strike 55.93 $
Difference Strike %+39.95%
Spread 0.003
Spread %7.50%
Theoretical value 0.0385
Implied Volatility 27.00 %
Total Loss Probability 97.31 %
Intrinsic value 0.000000
Present value 0.0385
Break even 140.42 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
84.07 USD
Average target price
94.07 USD
Spread / Average Target
+11.89%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW